We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Devgen and PT (Persero) Sang Hyang Seri sign memorandum of understanding on the introduction of biotech rice in Indonesia

Read time: Less than a minute

Devgen and PT (Persero) Sang Hyang Seri (SHS) herewith further strengthen their relationship. The companies have already ongoing agreements for R&D, production and distribution of non-transgenic hybrid rice in Indonesia.
 
"Bringing biotech traits to market will take several years and is a complex and stepwise regulatory and research process." Says Dr. Thierry Bogaert. "We are pleased to further strengthen our relationship with SHS, a strong partner in Indonesia." 
 
"We are pleased to work with Devgen, a leader in rice trait and hybrid seed technology" says Mr. Eddy Budiono, the President Director of Sang Hyang Seri. "With this cooperation we will, as per government guidance, provide the Indonesian farmer with the best, locally produced, hybrid rice to increase yield and productivity in the country. The result will be significantly realized in the next few years. "
 
Indonesia is South East Asia's largest rice growing country with approximately 12 million ha under rice cultivation.
Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.